Direct intratumoral injection of viral vectors supplying a functional copy of the mutated or inactivated NF2 gene to augment functional Merlin protein re-expression in NF2-deficient tumor cells under the control of the SC-specific promoter P0 resulted in both the death of tumor cells and a significant regression of well-established tumors [532]. Here, NF2 is linked to neoplasm.